These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18375524)

  • 21. pS2 negativity in postmenopausal women with ER+PgR+ infiltrating ductal breast carcinoma is associated with reduced hormone dependence and increased proliferation and aneuploidy of the tumors.
    Ruibal A; Schneider J; del Rio C; Arias J; Núñez MJ; Piqueras V; Tejerina A
    Int J Biol Markers; 1999; 14(3):186-8. PubMed ID: 10569142
    [No Abstract]   [Full Text] [Related]  

  • 22. HER2 as a prognostic factor in breast cancer.
    Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
    Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
    Calzada L; Salazar EL; Pedron Nuevo N
    Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of the cytosolic content of the pS2 protein in breast cancer].
    Tamargo F; Vizoso F; Lamelas ML; Rodil A; Vérez P; Raigoso P; Mulero M; Vázquez J; Roiz C; Allende MT
    Rev Esp Med Nucl; 2002 Feb; 21(1):28-33. PubMed ID: 11820999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microinvasive lobular carcinoma of the breast.
    Howat AJ; Armour A; Ellis IO
    Histopathology; 2000 Nov; 37(5):477-8. PubMed ID: 11119139
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of the expression on the CD44v5 adhesion molecule in invasive lobular carcinomas of the breast. Association between negativity and cellular S-phase fraction >7%.
    Ruibal A; Arias J; Del Rio MC; Schneider J; Tejerina A
    Int J Biol Markers; 2000; 15(2):195-6. PubMed ID: 10883896
    [No Abstract]   [Full Text] [Related]  

  • 27. [Does obesity modify recurrence-free interval in breast cancer?].
    Kurz C; Obermair A; Schemper W; Kubista E; Sevelda P
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():305-7. PubMed ID: 8118326
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.
    Walter V; Fischer C; Deutsch TM; Ersing C; Nees J; Schütz F; Fremd C; Grischke EM; Sinn P; Brucker SY; Schneeweiss A; Hartkopf AD; Wallwiener M
    Breast Cancer Res Treat; 2020 Aug; 183(1):137-144. PubMed ID: 32613540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
    Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
    J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The associations between mast cell infiltration, clinical features and molecular types of invasive breast cancer.
    Sang J; Yi D; Tang X; Zhang Y; Huang T
    Oncotarget; 2016 Dec; 7(49):81661-81669. PubMed ID: 27835573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
    Kuo SH; Chen CL; Huang CS; Cheng AL
    Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New European approvals: Alpelisib for HRpos/HER2neg metastatic breast cancer with PIK3CA mutation].
    Corbaux P; Sabatier R
    Bull Cancer; 2020 Oct; 107(10):959-960. PubMed ID: 32977934
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.
    Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM
    Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic targeting in breast cancer].
    Penault-Llorca F
    Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma.
    Spiethoff A; Schenck A; Bohrer M
    J Cancer Res Clin Oncol; 2000 Dec; 126(12):707-10. PubMed ID: 11153143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.
    Leers MP; Nap M
    Breast J; 2001; 7(4):249-59. PubMed ID: 11678803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer.
    Petit T; Wilt M; Velten M; Rodier JF; Fricker JP; Dufour P; Ghnassia JP
    Breast Cancer Res Treat; 2010 Nov; 124(2):387-91. PubMed ID: 20824324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas.
    Blanco MJ; Moreno-Bueno G; Sarrio D; Locascio A; Cano A; Palacios J; Nieto MA
    Oncogene; 2002 May; 21(20):3241-6. PubMed ID: 12082640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal-like immunophenotype markers and prognosis in early breast cancer.
    Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B
    Tumori; 2010; 96(6):966-70. PubMed ID: 21388060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.